arrow
H

Hirotaka Matsui

national cancer center - japan
H指数:35
被引数:3,638

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-world outcomes of chimeric antigen receptor T-cell therapy with pembrolizumab as holding and/or bridging therapy in relapsed/refractory primary mediastinal large B-cell lymphoma

嵌合抗原受体T细胞疗法联合帕博利珠单抗作为维持和/或桥接疗法在复发/难治性原发纵隔大B细胞淋巴瘤中的真实世界疗效

2026-04-130
PRE
T-cell fitness, metabolic tumor volume, and serum LDH levels are associated with response to axicabtagene ciloleucel

T细胞活力、代谢肿瘤体积和血清LDH水平与axicabtagene ciloleucel的反应相关

2026-01-010
PRE
Myeloid/natural killer (NK) cell precursor acute leukemia as a distinct leukemia type

骨髓/自然杀伤 (NK) 细胞前体急性白血病是一种独特的白血病类型

2023-12-152
OAAI
Biallelic disruption of DDX41 activity is associated with distinct genomic and immunophenotypic hallmarks in acute leukemia

DDX41活性的双等位基因破坏与急性白血病中不同的基因组和免疫表型标志相关

2023-06-264
OAAI
DDX41 coordinates RNA splicing and transcriptional elongation to prevent DNA replication stress in hematopoietic cells
LEUKEMIA
IF13.4
2022-10-1420
OAAI
DDX41 is required for cGAS-STING activation against DNA virus infection
2022-05-0150
OAAI
Prognostic value of left atrial strain in patients with wild-type transthyretin amyloid cardiomyopathy
2021-09-2811
OA
Elevated C-reactive protein is signi fi cantly associated with left ventricular dysfunction in patients with aortic regurgitation and concomitant collagen disease
2021-04-011
OAAI